AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for BEAM THERAPEUTICS · Biotechnology & drug development

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · posted Jul 16, 2025

Lobbying activity 1

Health Issues

-cell and gene therapy policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem